-
公开(公告)号:US12073932B2
公开(公告)日:2024-08-27
申请号:US17509670
申请日:2021-10-25
发明人: Benyamin Grosman , Di Wu , Louis J. Lintereur , Anirban Roy , Neha J. Parikh , Patrick E. Weydt , Ali Dianaty
CPC分类号: G16H20/17 , A61B5/4839 , A61M5/1723 , G16H50/50 , A61M2005/14208 , A61M2005/14288 , A61M2005/14296 , A61M2205/52 , A61M2230/201
摘要: Disclosed herein are techniques related to automatically adjusting at least one parameter of an insulin delivery controller of an insulin delivery device to regulate delivery of insulin to a user. In some embodiments, the techniques may involve obtaining therapy-related data associated with operation of the insulin delivery device for a number of days in the past. The therapy-related data including sensor glucose data for the user and meal data for the user. The techniques may also involve determining at least one adjusted parameter for the insulin delivery controller based on the therapy-related data. Additionally, the techniques may involve causing the insulin delivery controller to adjust at least one setting in accordance with the determined at least one adjusted parameter.
-
公开(公告)号:US11998721B2
公开(公告)日:2024-06-04
申请号:US18317877
申请日:2023-05-15
发明人: Louis J. Lintereur , Alexander S. Campbell , Dmytro Y. Sokolovskyy , Neha J. Parikh , Maria Diana Miller
CPC分类号: A61M5/1723 , G16H10/40 , G16H20/17 , G16H40/67 , A61M2205/18 , A61M2205/3584 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/702 , A61M2230/201
摘要: Techniques disclosed herein relate to continuous analyte sensor quality measures. In some embodiments, the techniques may involve obtaining a current sensor-generated value that is indicative of a physiological characteristic of a user of a medical device, the current sensor-generated value produced in response to operation of a continuous analyte sensor device. The techniques may further involve obtaining a sensor quality metric that indicates accuracy of the current sensor-generated value. The techniques may further involve causing, in response to obtaining the sensor quality metric, configuration of a quality-specific operating mode of the medical device, the quality-specific operating mode comprising separate regulation of basal and bolus deliveries of a fluid medication based on the obtained sensor quality metric. The techniques may further involve causing regulation of fluid medication delivery from the medical device, in accordance with the current sensor-generated value and the quality-specific operating mode of the medical device.
-
3.
公开(公告)号:US11992656B2
公开(公告)日:2024-05-28
申请号:US17005939
申请日:2020-08-28
CPC分类号: A61M5/1723 , A61B5/4809 , A61B5/746 , A61M5/14248 , A61M2205/18 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/587 , A61M2205/8206 , A61M2230/005 , A61M2230/201 , A61M2230/63
摘要: A method of operating an insulin infusion device involves: operating the infusion device in an automatic mode to automatically control delivery of insulin to a user, in accordance with a first target glucose setpoint value; receiving user status data that indicates sleeping status of the user, the user status data generated by a sleep detection system; and determining, from the user status data, that the user is sleeping while the insulin infusion device is operating in the automatic mode. In response to the determining, the method transitions from the first target glucose setpoint value to a second (different) target glucose setpoint value for use during the automatic mode, the transitioning occurring without user input. The method continues to operate the infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the second target glucose setpoint value.
-
公开(公告)号:US11944785B2
公开(公告)日:2024-04-02
申请号:US17112321
申请日:2020-12-04
发明人: Louis J. Lintereur , Catherine Tan Fogel , Patrick E. Weydt , Benyamin Grosman , Mahta Sadeghzadeh
IPC分类号: A61M5/172 , G06Q30/04 , G16H10/20 , G16H20/17 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , G16H50/70
CPC分类号: A61M5/1723 , G06Q30/04 , G16H10/20 , G16H20/17 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , G16H50/70 , A61M2205/3553 , A61M2205/502 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/8206 , A61M2230/201
摘要: Devices, systems, and techniques for therapy delivery and healthcare management is described. In one example, a system comprises a delivery device configured to execute therapy information comprising a treatment schedule specifying one or more treatments over a time period, wherein for each of the one or more treatments, the therapy information comprises a treatment type and a treatment amount; and processing circuitry configured to: determine a modification to the therapy information based on a recommendation of a digital twin, wherein the digital twin determines an estimated glucose level expected to be within a healthy range if the delivery device executes the modification to therapy information; and in response to physician review of the modification to the therapy information, output, to a healthcare provider system for the patient, data indicating completion of a healthcare service corresponding to the physician review.
-
公开(公告)号:US11694784B2
公开(公告)日:2023-07-04
申请号:US17080481
申请日:2020-10-26
发明人: Benyamin Grosman , Anirban Roy , Patrick E. Weydt , Neha J. Parikh , Louis J. Lintereur , Di Wu
IPC分类号: G16H20/17 , A61B5/00 , A61B5/145 , A61M5/142 , A61M5/172 , G16H50/50 , G16H50/20 , G16H10/20 , G16H10/60 , G16H20/60 , G16H40/63 , A61M5/145 , A61M5/168 , A61K38/28 , G16H20/30 , G16H50/30
CPC分类号: G16H20/17 , A61B5/14532 , A61B5/4839 , A61M5/142 , A61M5/145 , A61M5/14244 , A61M5/16831 , A61M5/1723 , G16H10/20 , G16H10/60 , G16H20/60 , G16H40/63 , G16H50/20 , G16H50/50 , A61B5/746 , A61B5/7465 , A61K38/28 , A61M5/16804 , A61M5/16877 , A61M2005/14208 , A61M2205/18 , A61M2205/3303 , A61M2205/35 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/8206 , A61M2230/201 , A61M2230/63 , G16H20/30 , G16H50/30
摘要: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves obtaining, by a control system associated with the infusion device, an input meal indication, obtaining historical data for the patient associated with the input meal indication, determining an estimated carbohydrate amount corresponding to the input meal indication based at least in part on the historical data, determining a bolus dosage of the insulin based at least in part on the estimated carbohydrate amount, and operating an actuation arrangement of the infusion device to deliver the bolus dosage of the insulin to the patient.
-
公开(公告)号:US20220257858A1
公开(公告)日:2022-08-18
申请号:US17179070
申请日:2021-02-18
发明人: Benyamin Grosman , Louis J. Lintereur , Anirban Roy , Neha J. Parikh , Di Wu , Patrick E. Weydt , David Dunleavy , Ali Dianaty
IPC分类号: A61M5/172
摘要: Techniques related to automatically generating a super bolus may include determining an amount of an augmented meal bolus to be delivered to a patient for regulating the patient's glycemic response to a meal. The amount of the augmented meal bolus may exceed a sufficient amount for counteracting a glucose level increase caused by the meal. In some embodiments, the techniques may further include determining a duration of a postprandial reduction period during which basal dosage deliveries to the patient are to be reduced. In some other embodiments, the techniques may further include delivering the augmented meal bolus to the patient prior to determining whether or not to cause reduction of basal dosage deliveries. More specifically, a glucose level of the patient may be obtained after delivery of the augmented meal bolus, and the obtained glucose level may be used to determine whether to reduce basal dosage deliveries.
-
公开(公告)号:US20220143314A1
公开(公告)日:2022-05-12
申请号:US17090938
申请日:2020-11-06
摘要: Devices, systems, and techniques for guiding therapy delivery to a diabetes patient is described. Some devices, systems, and techniques proactively monitor the patient's food consumption and (if needed) adapt the patient's diabetes therapy accordingly. In one example, a system comprises one or more sensors configured to capture a representation of the object, and processing circuitry configured to determine data corresponding to the representation of the object, wherein the data comprises information identifying the object as a particular food item; generate food item information based on the information identifying the object as the particular food item, wherein the food item information comprises at least one of nutrition information or volume information of the particular food item, generate therapy information for the patient based on the food item information, and output content indicative of at least one of the therapy information or the food item information.
-
公开(公告)号:US20220088306A1
公开(公告)日:2022-03-24
申请号:US17541673
申请日:2021-12-03
发明人: Anirban Roy , Benyamin Grosman , Neha J. Parikh , Di Wu , Louis J. Lintereur
摘要: Disclosed are techniques related to determination of adjustments to fluid delivery settings. The techniques may involve accessing an input meal size category, where the input meal size category is selected from among a plurality of meal size categories via a user interface; accessing a plurality of groups of historical meal events for a person, where each group of the plurality of groups is associated with a respective meal size category of the plurality of meal size categories and includes respective historical meal events for the person categorized in the respective meal size category; identifying a group, in the plurality of groups of historical meal events for the person, having ane associated meal size category that matches the input meal size category; identifying a person-specific carbohydrate amount representative of the historical meal events in the identified group; and determining a bolus dosage value of insulin based on the person-specific carbohydrate amount.
-
9.
公开(公告)号:US20210330883A1
公开(公告)日:2021-10-28
申请号:US16856838
申请日:2020-04-23
发明人: Louis J. Lintereur , Alexander S. Campbell , Dmytro Y. Sokolovskyy , Neha J. Parikh , Maria Diana Miller
摘要: Disclosed is a method of controlling operation of a medical device that regulates delivery of a fluid medication to a user. The method obtains a current sensor-generated value that is indicative of a physiological characteristic of the user, and is produced in response to operation of a continuous analyte sensor device. The method continues by: calculating a sensor quality metric that indicates reliability and trustworthiness of the current sensor-generated value; adjusting, in response to the calculated sensor quality metric, therapy actions of the medical device to configure a quality-specific operating mode of the medical device; managing generation of user alerts at the medical device in response to the calculated sensor quality metric; and regulating delivery of the fluid medication from the medical device, in accordance with the current sensor-generated value and the quality-specific operating mode of the medical device.
-
公开(公告)号:US20210228805A1
公开(公告)日:2021-07-29
申请号:US17231583
申请日:2021-04-15
发明人: Louis J. Lintereur , Anirban Roy , Benyamin Grosman , Patrick E. Weydt , Neha J. Parikh , Di Wu , Ali Dianaty
摘要: Medical devices and related systems and operating methods are provided. A method of operating an infusion device capable of delivering fluid influencing a physiological condition to a patient involves obtaining an event indication, such as a meal indication, determining an initial bolus amount based on the event indication, and determining predicted values for the physiological condition of the patient during a time window into the future based at least in part on the initial bolus amount. When the predicted values violate a threshold during the time window, the control system identifies an adjusted bolus amount that results in the predicted values for the physiological condition satisfying the threshold during the time window from within a search space defined by the initial bolus amount and operates an actuation arrangement of the infusion device to deliver the adjusted bolus amount of the fluid to the patient.
-
-
-
-
-
-
-
-
-